Research Progress on the Treatment of Gestational Hypertension with Traditional Chinese and Western Medicine

Authors

  • Jingjing Yang Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Lihong Zhu The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China

DOI:

https://doi.org/10.53469/jcmp.2024.06(11).07

Keywords:

Hypertensive disorders of pregnancy, Integrated Chinese and Western medicine treatment, Clinical efficacy, Pathogenic mechanism

Abstract

Hypertensive disorders of pregnancy (HDP) is a disease with high incidence in the middle and late stages of pregnancy, characterized by systemic small vessel spasm and endothelial injury as the main pathological and physiological changes, and its etiology and pathogenesis are still unclear. Traditional Chinese medicine theory is that, for the etiology and pathogenesis of gestational hypertension more empty mark real syndrome, which are closely related to the imbalance of liver, spleen, and kidney functions. On the other hand, Western medicine believes that the onset of gestational hypertension is related to factors such as poor placental formation and systemic inflammatory reactions. At present, both Chinese and Western medicine have achieved good efficacy in the clinical treatment of gestational hypertension. In recent years, the integrated treatment strategy of Chinese and Western medicine has provided new ideas and options for the treatment of gestational hypertension, which is expected to further improve the therapeutic efficacy of patients and improve maternal and neonatal outcomes. The review aims to explore the application and clinical efficacy of integrated Chinese and Western medicine programs in the treatment of gestational hypertension by reviewing the relevant literature in recent years, with the expectation that it will provide reference for further in-depth research and clinical practice, promote the early diagnosis and treatment of gestational hypertension, and reduce the incidence of adverse outcomes in both mother and child.

References

Garovic VD, Dechend R, Easterling T, et al. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022 Feb; 79(2): e21-e41.

Bridwell M, Handzel E, Hynes M, et al. Hypertensive disorders in pregnancy and maternal and neonatal outcomes in Haiti: the importance of surveillance and data collection. BMC Pregnancy Childbirth. 2019 Jun 20; 19(1):208.

Teng H, Wang Y, Han B, et al. Gestational systolic blood pressure trajectories and risk of adverse maternal and perinatal outcomes in Chinese women. BMC Pregnancy Childbirth. 2021 Feb 22; 21(1):155.

Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun; 2(6): e323-33.

Ives CW, Sinkey R, Rajapreyar I, et al. Preeclampsia - Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Oct 6; 76(14):1690-1702.

Haßdenteufel K, Müller M, Gutsfeld R, et al. Long-term effects of preeclampsia on maternal cardiovascular health and postpartum utilization of primary care: an observational claims data study. Arch Gynecol Obstet. 2023 Jan; 307(1):275-284.

Brown MA, Magee LA, Kenny LC, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018 Jul; 72(1): 24-43.

GUO Liping, LIU Mei, JI Xiao, et al. Research progress on traditional Chinese medicine treatment of gestational hypertension [J]. Journal of Emergency in Traditional Chinese Medicine. 2022, 31(01):181-184.

Pregnancy Hypertension Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China (2020). Chinese Journal of Obstetrics and Gynecology. 2020, 55(04):227-238.

Magee LA, Smith GN, Bloch C, et al. Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management. J Obstet Gynaecol Can. 2022 May; 44(5):547-571. e1.

ZHANG Yuzhen. TCM gynaecology [M]. China Traditional Chinese Medicine Press. 2002:263.

ZHENG De-zhu; JIANG Jun-wen. Research Progress of Traditional Chinese Medicine on Hypertensive Disorder Complicating Pregnancy [J]. Chinese Manipulation and Rehabilitation Medicine. 2022, 13(06):74-77.

Yu Jiaqi, Fu Shufei. Analysis of the ancient gynecological experts' use of the diagnosis and treatment concept of "if blood is not good, it is water" [J]. Lishizhen Medicine and Materia Medica Research. 2019, 30(02):435-437.

Xiong Shuling, Hu Mengjie, Liu Peirong. Research on the Relationship between Traditional Chinese Medicine Constitution of Pregnant Women and Pregnancy induced Hypertension [J]. Practical Clinical Medicine. 2016, 17(12):12-13.

Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009 Mar; 30 Suppl A: S38-42.

Redman C. The six stages of pre-eclampsia. Pregnancy Hypertens. 2014 Jul; 4(3):246.

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019 Mar 29; 124(7):1094-1112.

Schoots MH, Bourgonje MF, Bourgonje AR, et al. Oxidative stress biomarkers in fetal growth restriction with and without preeclampsia. Placenta. 2021 Nov; 115:87-96.

Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019 May; 15(5):275-289.

Rahimzadeh M, Norouzian M, Arabpour F, Naderi N. Regulatory T-cells and preeclampsia: an overview of literature. Expert Rev Clin Immunol. 2016; 12(2): 209-27.

Salvany-Celades M, van der Zwan A, Benner M, et al. Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface. Cell Rep. 2019 May 28; 27(9):2537-2547. e5.

Liu Xijing, Zhou Rong. Gestational diet management in prevention of preeclampsia [J]. Chinese Journal of Practical Gynecology and Obstetrics. 2018, 34(05): 508-512.

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol. 2020 Jun; 135(6):1492-1495.

Butalia S, Audibert F, Côté AM, et al. Hypertension Canada. Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy. Can J Cardiol. 2018 May; 34(5):526-531.

WHO recommendations on drug treatment for non-severe hypertension in pregnancy [Internet]. Geneva: World Health Organization; 2020. PMID: 32845596.

WHO recommendation: Calcium supplementation during pregnancy for the prevention of pre-eclampsia and its complications. Geneva: World Health Organization; 2018. PMID: 30629391.

Melzer K, Schutz Y, Boulvain M, Kayser B. Physical activity and pregnancy: cardiovascular adaptations, recommendations and pregnancy outcomes. Sports Med. 2010 Jun 1; 40(6):493-507.

Chen Peng, Liu Xinghui. Pregnancy nutrition and preeclampsia[J]. Chinese Journal of Perinatal Medicine. 2014, 17(02):131-134.

Liu Dongrong, Zhuang Zebin, Guo Shaoyan, et al. Research progress on pathogenesis and TCM prevention and treatment of pre-eclampsia[J]. Journal of Guangdong Pharmaceutical University. 2022, 38(02): 131-137.

GU Shaohua; LIU Qiaofang; LI Xiangnan; et al. Effect of Qiju Dihuang Pill on Serum Factor Level in Patients with Pregnancy Induced Hypertension of Liver Kidney Yin Deficiency and Its Mechanism[J]. Chinese Archives of Traditional Chinese Medicine. 2021, 39(02): 248-251+290.

ZHAO Yaning; CAO Jing; YANG Jing; et al. Impact of Modified Tianma Gouteng Decoction on the Micro-inflammatory State, Blood Coagulation Function as well as Renal Function in Patients with Severe Preeclampsia [J]. Journal of Liaoning University of Traditional Chinese Medicine. 2019, 21(04):35-38.

LU Tao; LU Jia-Bin; YUAN Feng-Gang; et al. Effects of Banxia Baizhu Tianma Decoction Combined with Low-dose Low-molecular-weight Heparin Calcium on Coagulation Function and Maternal and Infant Outcomes in Patients with Early Onset Severe Preeclampsia[J]. Journal of Guangzhou University of Traditional Chinese Medicine. 2022, 39(03):545-550.

Zhao Wei, Qin Xiaopei, Jing Qi, et al. Observation on the therapeutic effect of traditional Chinese medicine in preventing and treating gestational hypertension [J]. Chinese Medicine Modern Distance Education of China. 2012, 10(09):142-143.

JIA Rui; LI Jianwu; LIU Lixia; et al. Clinical Study on Zishen Qinggan Huayu Prescription Combined with Aspirin Enteric- Coated Tablets for Preeclampsia [J]. New Chinese Medicine. 2021, 53(23):129-133.

ZHANG Kai-ge; ZHANG Yan-zi; SUN Hang; et al. Effects of Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection on placental PLGF and sFLT-1 in hypertensive disorder complicating pregnancy rats[J]. Journal of Clinical and Experimental Medicine. 2022, 21(15):1576-1579.

Han Jie, Cao Lina, Zhang Chao, et al. The effect of acupoint massage on sleep and blood pressure in pregnant women with gestational hypertension [J]. Maternal and Child Health Care of China. 2019, 34(06):1426-1428.

Ye Huaying. The effect of acupoint massage on sleep quality and blood pressure of hospitalized patients with preeclampsia [J]. Women’s Health Research. 2020, (06):102-103.

Yang Yang, Xiao Hong, Xiao Delong, et al. The intervention effect of ear acupressure on high-risk women with gestational hypertension [J]. Maternal and Child Health Care of China. 2015, 30(36):6459-6462.

LAN Xiaohong; GUO Xueqi; LIU Xiandang; et al. Clinical Observation of Integrated Chinese and Western Medicine Therapy Combined with Nursing Intervening Gestational Hypertension with Syndrome of Hyperactivity of Yang due to Yin Deficiency. New Chinese Medicine. 2018, 50(12):242-245.

Downloads

Published

2024-11-28

How to Cite

Yang, J., & Zhu, L. (2024). Research Progress on the Treatment of Gestational Hypertension with Traditional Chinese and Western Medicine. Journal of Contemporary Medical Practice, 6(11), 32–37. https://doi.org/10.53469/jcmp.2024.06(11).07